ClariVest Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $826 | Hold |
12
| – | – | ﹤0.01% | 665 |
|
|
2024
Q2 | $826 | Buy |
12
+1
| +9% | +$67 | ﹤0.01% | 665 |
|
|
2024
Q1 | $803 | Sell |
11
-141
| -93% | -$10.8K | ﹤0.01% | 706 |
|
|
2023
Q4 | $12.3K | Buy |
152
+1
| +0.7% | +$78 | ﹤0.01% | 396 |
|
|
2023
Q3 | $11K | Sell |
151
-34
| -18% | -$2.62K | ﹤0.01% | 391 |
|
|
2023
Q2 | $14K | Hold |
185
| – | – | ﹤0.01% | 374 |
|
|
2023
Q1 | $15K | Buy |
185
+34
| +23% | +$2.82K | ﹤0.01% | 435 |
|
|
2022
Q4 | $14K | Buy |
151
+88
| +140% | +$6.97K | ﹤0.01% | 449 |
|
|
2022
Q3 | $4K | Buy |
63
+8
| +15% | +$504 | ﹤0.01% | 487 |
|
|
2022
Q2 | $4K | Hold |
55
| – | – | ﹤0.01% | 505 |
|
|
2022
Q1 | $4K | Buy |
55
+12
| +28% | +$767 | ﹤0.01% | 548 |
|
|
2021
Q4 | $3K | Hold |
43
| – | – | ﹤0.01% | 602 |
|
|
2021
Q3 | $3K | Hold |
43
| – | – | ﹤0.01% | 595 |
|
|
2021
Q2 | $3K | Hold |
43
| – | – | ﹤0.01% | 587 |
|
|
2021
Q1 | $3K | Hold |
43
| – | – | ﹤0.01% | 572 |
|
|
2020
Q4 | $3K | Hold |
43
| – | – | ﹤0.01% | 608 |
|
|
2020
Q3 | $3K | Hold |
43
| – | – | ﹤0.01% | 592 |
|
|
2020
Q2 | $3K | Buy |
43
+6
| +16% | +$460 | ﹤0.01% | 663 |
|
|
2020
Q1 | $2K | Buy |
+37
| New | +$2.56K | ﹤0.01% | 628 |
|
|
2017
Q4 | – | Sell |
-3,567
| Closed | -$289K | – | 733 |
|
|
2017
Q3 | $289K | Buy |
3,567
+532
| +18% | +$40.7K | 0.01% | 447 |
|
|
2017
Q2 | $215K | Buy |
3,035
+1,792
| +144% | +$119K | 0.01% | 466 |
|
|
2017
Q1 | $85K | Sell |
1,243
-460,153
| -100% | -$32.4M | ﹤0.01% | 569 |
|
|
2016
Q4 | $33M | Sell |
461,396
-2,007
| -0.4% | -$149K | 0.88% | 30 |
|
|
2016
Q3 | $36.7M | Sell |
463,403
-239,789
| -34% | -$19.5M | 1.06% | 28 |
|
|
2016
Q2 | $58.7M | Sell |
703,192
-4,680
| -0.7% | -$415K | 1.75% | 9 |
|
|
2016
Q1 | $65M | Sell |
707,872
-64,500
| -8% | -$5.82M | 1.97% | 6 |
|
|
2015
Q4 | $78.2M | Sell |
772,372
-9,202
| -1% | -$957K | 2.21% | 5 |
|
|
2015
Q3 | $76.7M | Buy |
781,574
+36,727
| +5% | +$4.08M | 2.31% | 3 |
|
|
2015
Q2 | $87.2M | Buy |
744,847
+1,500
| +0.2% | +$164K | 2.6% | 3 |
|
|
2015
Q1 | $72.9M | Buy |
743,347
+33,448
| +5% | +$3.4M | 2.23% | 3 |
|
|
2014
Q4 | $66.9M | Buy |
709,899
+224,072
| +46% | +$23.2M | 2.36% | 5 |
|
|
2014
Q3 | $51.7M | Sell |
485,827
-145
| -0% | -$14.2K | 1.9% | 5 |
|
|
2014
Q2 | $40.3M | Sell |
485,972
-29,653
| -6% | -$2.31M | 1.52% | 8 |
|
|
2014
Q1 | $36.5M | Buy |
515,625
+3,396
| +0.7% | +$266K | 1.48% | 14 |
|
|
2013
Q4 | $38.5M | Sell |
512,229
-20,060
| -4% | -$1.4M | 1.62% | 13 |
|
|
2013
Q3 | $33.5M | Sell |
532,289
-94,515
| -15% | -$5.65M | 1.53% | 10 |
|
|
2013
Q2 | $32.1M | Buy |
+626,804
| New | +$32.7M | 1.44% | 12 |
|
Other funds holding GILD
ClariVest Asset Management's GILD Position: Q3 2024 in Review
ClariVest Asset Management held its Gilead Sciences (GILD) position steady in Q3 2024 at 12 shares worth $826. The position accounts for ﹤0.01% of the portfolio, ranked #665.
ClariVest Asset Management first reported a position in GILD in Q2 2013 and has held it in 37 quarters since. The position peaked at $87.2M in Q2 2015. 1,719 funds tracked by Wall St. Rank hold GILD as of Q3 2024.
- ClariVest Asset Management held 12 shares of Gilead Sciences worth $826 as of Q3 2024.
- ClariVest Asset Management left its Gilead Sciences share count unchanged in Q3 2024.
- Gilead Sciences made up ﹤0.01% of ClariVest Asset Management's portfolio in Q3 2024, its #665 holding.
- ClariVest Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 37 quarters since.
- ClariVest Asset Management's Gilead Sciences position peaked at $87.2M in Q2 2015.
- 1,719 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.
Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.